Background: The world's practice has shown the importance of rehabilitation, which reduces the risks of developing complications after COVID-19.
Purpose: We developed and investigated the effectiveness of the telemedicine platform Сovidrehab in order to enhance the effectiveness of the recovery period during self-isolation.
Methods: The study involved 3508 patients aged 50 to 94 years (mean age 62 years) who had a moderate disease of COVID-19. 73.3% of study population (2571/3508) were women and 27.7% (937/3508) were men. We used the specialised platform Сovidrehab for remote monitoring of the rehabilitation efficiency of patients who suffered from COVID-19. During the study, the supervising doctor assigned the patient a set of specialised questionnaires, which were filled in online. The questionnaires distributed to the patient included questions specifically designed for the Сovidrehab remote platform as well as the mMRC (Modified Medical Research Council) questionnaire.
Results: Patients who completed the comprehensive medical rehabilitation program using the information and analytical system Сovidrehab, were found to have positive dynamics of indicators of the respiratory system functional state, and complaints. After completing a course of remote rehabilitation 38% of patients stopped feeling weak (p <0.05 vs baseline); 24% of patients stopped having difficulty breathing (p <0.05 vs baseline); in 21% of patients, shortness of breath disappeared (p <0.05 vs baseline); in 19% of patients increased muscle mass (p <0.05 vs baseline); tachycardia disappeared in 18% of patients (p <0.05 vs baseline), and 16% of the study participants stopped experiencing a feeling of lack of oxygen (p <0.05 vs baseline).
Conclusions: The online approach to rehabilitation improves the functioning of the respiratory and cardiovascular systems, restores physical function, reduces anxiety and depression, and restores quality of life. An essential benefit of this program is the prevention of secondary complications and reduction of serious adverse effects of COVID-19 treatment.